期刊文献+

健脾祛瘀方联合卡培他滨、伊立替康治疗晚期大肠癌20例 被引量:7

Clinical study of Jianpi Quyu Decoction with Chemotherapy in the Treatment of Patients with Advanced Colorectal Tumor
下载PDF
导出
摘要 [目的]观察健脾祛瘀方联合卡培他滨、伊立替康治疗晚期大肠癌疗效。[方法]将40例随机分为两组。对照组20例采用卡培他滨(Xeloda)+伊立替康(CPT-11)方案;治疗组采用健脾祛瘀方联合化疗。观察CEA值、Karnofsky评分、生活质量评分及血常规、肝肾功能等安全性指标,治疗两个月进行疗效判定。[结果]健脾祛瘀方联合化疗治疗晚期大肠癌,在降低CEA值、改善体力状况、提高患者生活质量等方面优于单纯化疗。[结论]中西医结合治疗晚期大肠癌可提高疗效减轻副作用。 [Objective] To observe the efficacy and Side effects of Jianpi Quyu decoction with chemotherapy in the treatment of patients with advanced colorectal tumor.[Methods]40 cases included in the standard of advanced colorectal cancer patients are divided into treatment group and control group,the treatment group of 20 cases,20 cases of the control group.Treatment group used the chemotherapy treatment and Jianpi Quyu decoction;Control group with the chemotherapy treatment group;chemotherapy using capecitabine(Xeloda) + irinotecan(CPT-11).We recorded the CEA,Karnofsky score,the quality of life score and blood,liver and kidney function,and other safety indicators before and after treatment,and statistic the results with statistical software.[Results]Jianpi Quyu decoction with chemotherapy in the treatment of advanced colorectal cancer in the lower value of CEA,improving physical conditions and the quality of life is better than chemotherapy alone.[Conclusion]Integrative Medicine on the treatment of advanced colorectal cancer can improve the efficacy of reducing side effects.
作者 崔虎军
出处 《实用中医内科杂志》 2011年第8期48-50,共3页 Journal of Practical Traditional Chinese Internal Medicine
关键词 晚期大肠癌 卡培他滨 伊立替康 健脾祛瘀方 CEA值 KARNOFSKY评分 生活质量评分 临床观察 中西医结合治疗 Advanced colorectal cancer capecitabine irinotecan Jianpi Quyu decoction CEA value Karnofsky score quality of life score clinical observation combine TCM and western medicine treatment
  • 相关文献

参考文献11

  • 1Pasetto LM,Jirillo A,Iadicicco G,et al.FOLFOX versus FOLFIRI:a comparison of regimens in the treatment of colorectal cancer metastases[J].Anticancer Res,2005,25 (1 B):563-76.
  • 2Bengtsson G,Carlsson G,Hafstrom L,et al.Natural history of patients with untreated liver metastases from colorectal cancer[J].Am J surg,1981,141 (3):556-589.
  • 3Simmonds PC.Palliative chemotherapy for advanced colorectal cancer:systematic reciew and meta-analysis[J].BMJ 2000,321(7260):531-535.
  • 4Arkenau H,Schmoll H,Kubicka S,et al.Infusional 5-fluorouracil/folinic acid plus oxaliplatin(FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first-line treatment of metastatic colorectal cancer (MCRC):Results of the safety and efficacy analysis[J].Proc Am Soc Clin Oncol,2005:abstr 3507.
  • 5Gunderson LL,Martin JK,Beart RW,et al.Adjucant irradiation of rectal cancer[J].Int J Radiat Oncol Biol Phys,1987,13:141.
  • 6刘军.卡培他滨(希罗达)用于结肠癌术后辅助化疗.中国医学论坛报,2005,.
  • 7杨丽娟,王润田,刘京生,佟慧,邓郁青,李全海.黄芪对S180肿瘤培养上清免疫抑制作用的影响[J].中国肿瘤生物治疗杂志,2003,10(3):210-213. 被引量:16
  • 8许杜娟,陈敏珠.黄芪多糖的抑瘤作用及其机制[J].中国医院药学杂志,2005,25(10):923-925. 被引量:96
  • 9范伟忠,章荣华,傅剑云.薏苡仁油对小鼠移植性肿瘤的影响[J].上海预防医学,2000,12(5):210-211. 被引量:16
  • 10冯玉书 桂绿荷 徐暑民.鹤草酚抗肿瘤作用的实验研究[J].沈阳药学院学报,1980,(10):62-62.

二级参考文献19

  • 1李凤云,陈浩然,冯晓东,柳世英,姜力.中药薏苡仁抗肿瘤作用的研究[J].实用肿瘤学杂志,1994,8(3):59-59. 被引量:37
  • 2杨金明,郭红梅.黄芪对S1802荷瘤小鼠的免疫增强及抑瘤作用[J].中国实验临床免疫学杂志,1995,7(1):41-44. 被引量:20
  • 3马占好,张春艳,刘旭,李殿俊,赵强,张万峰,王日芝,韩丽珍.黄芪多糖对小鼠体内六种细胞系瘤株抑瘤作用的实验研究[J].中医药学报,1996,24(4):55-56. 被引量:54
  • 4Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor in human disease [ J ]. N Engl J Med, 2000, 342(18) : 1350-1358.
  • 5Teraoka H, Sawada T, Yamashita Y, et at. TGF-betal promotes liver metastasis of pancreatic cancer by modulating the capacity of cellular invasion[J]. Int J Oncol, 2001, 19(-4): 709-715.
  • 6Chcry JA. Expression of regeneration and tolerance factor on B cell chronic lymphocytic lcukcmias: A possible mechanism for escaping immune survc-illance[J]. Am J Hematolo, 1999, 61: 46-61.
  • 7赵长琦 许有玲 王亚洲.抗肿瘤植物摇及其有效成分[M].北京:中国中医药出版社,1995.2-24.
  • 8Geng YJ, Hellstrand K. Apoptotic death of human leukemic cells induced by vascular cells expressing nitric oxide syntheses in response to gamma-interferon and tumor necrosis factor-alpha[J].Cancer Res,1996,56(4) :866~874.
  • 9顾关云.慧苡仁的药理作用[J].中成药,1990,(12):38-39.
  • 10卫生部.保健食品功能评价程序和检验方法.1996.1-26.

共引文献196

同被引文献174

引证文献7

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部